141 related articles for article (PubMed ID: 27228633)
1. Can Cannabinoids Modulate Fibrotic Progression in Systemic Sclerosis?
Garcia-Gonzalez E; Galeazzi M; Selvi E
Isr Med Assoc J; 2016; 18(3-4):156-8. PubMed ID: 27228633
[No Abstract] [Full Text] [Related]
2. Cannabinoid system and neuroinflammation: implications for multiple sclerosis.
Correa F; Docagne F; Mestre L; Loría F; Hernangómez M; Borrell J; Guaza C
Neuroimmunomodulation; 2007; 14(3-4):182-7. PubMed ID: 18073512
[TBL] [Abstract][Full Text] [Related]
3. CB receptor ligands from plants.
Woelkart K; Salo-Ahen OM; Bauer R
Curr Top Med Chem; 2008; 8(3):173-86. PubMed ID: 18289087
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective agents: cannabinoids.
Sánchez AJ; García-Merino A
Clin Immunol; 2012 Jan; 142(1):57-67. PubMed ID: 21420365
[TBL] [Abstract][Full Text] [Related]
5. Systemic sclerosis refractory disease: from the skin to the heart.
Almeida I; Faria R; Vita P; Vasconcelos C
Autoimmun Rev; 2011 Sep; 10(11):693-701. PubMed ID: 21575745
[TBL] [Abstract][Full Text] [Related]
6. The Immune Endocannabinoid System of the Tumor Microenvironment.
Kienzl M; Kargl J; Schicho R
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255584
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulatory Role of Cannabinoids during Infectious Disease.
Hernández-Cervantes R; Méndez-Díaz M; Prospéro-García Ó; Morales-Montor J
Neuroimmunomodulation; 2017; 24(4-5):183-199. PubMed ID: 29151103
[TBL] [Abstract][Full Text] [Related]
8. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease.
Ruzek MC; Jha S; Ledbetter S; Richards SM; Garman RD
Arthritis Rheum; 2004 Apr; 50(4):1319-31. PubMed ID: 15077316
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids and the immune system: an overview.
Tanasescu R; Constantinescu CS
Immunobiology; 2010 Aug; 215(8):588-97. PubMed ID: 20153077
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis.
Marquart S; Zerr P; Akhmetshina A; Palumbo K; Reich N; Tomcik M; Horn A; Dees C; Engel M; Zwerina J; Distler O; Schett G; Distler JH
Arthritis Rheum; 2010 Nov; 62(11):3467-76. PubMed ID: 20617520
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoids and multiple sclerosis: a blessing from the 'inner bliss'?
Di Marzo V; Bifulco M; De Petrocellis L
Trends Pharmacol Sci; 2000 Jun; 21(6):195-7. PubMed ID: 10838598
[No Abstract] [Full Text] [Related]
12. Cannabinoids for the treatment of inflammation.
Ashton JC
Curr Opin Investig Drugs; 2007 May; 8(5):373-84. PubMed ID: 17520866
[TBL] [Abstract][Full Text] [Related]
13. [Research progress on anti-inflammatory effects of plant-derived cannabinoid type 2 receptor modulators].
Lian CX; Hu SJ; Zhang QY; Zhao QM; Qin LP; Gong W
Zhongguo Zhong Yao Za Zhi; 2023 Dec; 48(23):6294-6306. PubMed ID: 38211986
[TBL] [Abstract][Full Text] [Related]
14. An endocannabinoid hypothesis of drug reward and drug addiction.
Onaivi ES
Ann N Y Acad Sci; 2008 Oct; 1139():412-21. PubMed ID: 18991888
[TBL] [Abstract][Full Text] [Related]
15. Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis.
Kapoor M; McCann M; Liu S; Huh K; Denton CP; Abraham DJ; Leask A
Arthritis Rheum; 2009 Sep; 60(9):2822-9. PubMed ID: 19714649
[TBL] [Abstract][Full Text] [Related]
16. Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literature.
Daoussis D; Liossis SN; Tsamandas AC; Kalogeropoulou C; Kazantzi A; Korfiatis P; Yiannopoulos G; Andonopoulos AP
Semin Arthritis Rheum; 2010 Oct; 40(2):127-36. PubMed ID: 20004954
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease.
O'Sullivan SE; Kendall DA
Immunobiology; 2010 Aug; 215(8):611-6. PubMed ID: 19833407
[TBL] [Abstract][Full Text] [Related]
18. When connective tissues lay it on a bit too thick: systemic sclerosis, autoantibodies, and fibrous tissue proliferation.
Luft FC
J Mol Med (Berl); 1998 Jan; 76(1):1-2. PubMed ID: 9462861
[No Abstract] [Full Text] [Related]
19. Potential roles of interleukin-17A in the development of skin fibrosis in mice.
Okamoto Y; Hasegawa M; Matsushita T; Hamaguchi Y; Huu DL; Iwakura Y; Fujimoto M; Takehara K
Arthritis Rheum; 2012 Nov; 64(11):3726-35. PubMed ID: 22833167
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis.
Sakkas LI; Chikanza IC; Platsoucas CD
Nat Clin Pract Rheumatol; 2006 Dec; 2(12):679-85. PubMed ID: 17133253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
